skip to main content

Main Site Navigation

Top of main content

Clinical Trials Details

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with Hypertension

Location: Carle - Heart & Vascular Institute
Body site or condition: Cardiovascular
Department: Cardiology

CR0002 - Target BP I

The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization.

Apply Now